Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model

Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are highly expressed in nasopharyngeal carcinoma; therefore, blocking the binding of VEGF and VEGFR may be a potential way to treat nasopharyngeal carcinoma. Apatinib inhibits tumor angiogenesis. Previous studies have suggested that...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shanshan, Wu, Fei, Zhang, Yanling, Qin, Rongsheng, Zhu, Nengping, Li, Yuan, Wang, Mingting, Zeng, Qin, Xie, Danna, Li, Yinghua, Fan, Juan, Han, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235534/
https://www.ncbi.nlm.nih.gov/pubmed/32420748
http://dx.doi.org/10.1177/1073274820922553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235534/
https://www.ncbi.nlm.nih.gov/pubmed/32420748
http://dx.doi.org/10.1177/1073274820922553

Ejemplares similares